We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Sunday
May 04
10:30 - 11:30
Plenary Hall
Head & neck 1
Erika Korobeinikova, Lithuania;
Nejla Fourati, Tunisia
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
Proffered Papers
Clinical
Head & Neck
10:30 - 10:40
Treatment Response-Adapted Risk Index Model for Survival Prediction and Adjuvant Chemotherapy Selection in Nonmetastatic Nasopharyngeal Carcinoma
Yang Liu, China
E25-1897
10:40 - 10:50
Time-to-event descriptive analysis on a large-scale multi-institutional dataset of mandibular ORN cases: the PREDMORN study cohort
Laia Humbert-Vidan, USA
E25-3040
10:50 - 11:00
Postoperative SBRT for Early-Stage Oropharyngeal and Oral Cavity Cancers with High-Risk Margins: the STEREOPOSTOP GORTEC 2017-03 phase 2 trial
Julian Biau, France
E25-2449
11:00 - 11:10
Impact of the introduction of “5+5” contouring on efficacy and swallowing outcomes in the phase 3 randomised CompARE trial.
Charles Fong, United Kingdom
E25-1386
11:10 - 11:20
HYpofractionated, Dose-redistributed RAdiotherapy (HYDRA) for head and neck cancer: dosimetric comparison and planned interim analysis results
Pascal Gunsch, The Netherlands
E25-1170